NO307782B1 - Anvendelse av fluorinert vitamin D3-derivat - Google Patents

Anvendelse av fluorinert vitamin D3-derivat

Info

Publication number
NO307782B1
NO307782B1 NO950920A NO950920A NO307782B1 NO 307782 B1 NO307782 B1 NO 307782B1 NO 950920 A NO950920 A NO 950920A NO 950920 A NO950920 A NO 950920A NO 307782 B1 NO307782 B1 NO 307782B1
Authority
NO
Norway
Prior art keywords
derivative
fluorinated vitamin
silyl
fluorinated
vitamin
Prior art date
Application number
NO950920A
Other languages
English (en)
Norwegian (no)
Other versions
NO950920D0 (no
NO950920L (no
Inventor
Thomas I Doran
Shian-Jan Shiuey
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO950920D0 publication Critical patent/NO950920D0/no
Publication of NO950920L publication Critical patent/NO950920L/no
Publication of NO307782B1 publication Critical patent/NO307782B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO950920A 1994-03-11 1995-03-10 Anvendelse av fluorinert vitamin D3-derivat NO307782B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08212453 US5384314B1 (en) 1994-03-11 1994-03-11 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (3)

Publication Number Publication Date
NO950920D0 NO950920D0 (no) 1995-03-10
NO950920L NO950920L (no) 1995-09-12
NO307782B1 true NO307782B1 (no) 2000-05-29

Family

ID=22791087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950920A NO307782B1 (no) 1994-03-11 1995-03-10 Anvendelse av fluorinert vitamin D3-derivat

Country Status (22)

Country Link
US (1) US5384314B1 (fr)
EP (1) EP0671387B1 (fr)
JP (1) JP2659345B2 (fr)
KR (1) KR100360732B1 (fr)
CN (1) CN1051227C (fr)
AT (1) ATE165595T1 (fr)
AU (1) AU687972B2 (fr)
BR (1) BR9501035A (fr)
CA (1) CA2141652C (fr)
CZ (1) CZ288793B6 (fr)
DE (1) DE69502223T2 (fr)
DK (1) DK0671387T3 (fr)
ES (1) ES2116634T3 (fr)
FI (1) FI112323B (fr)
HU (1) HU219906B (fr)
IL (1) IL112887A0 (fr)
NO (1) NO307782B1 (fr)
NZ (1) NZ270624A (fr)
PH (1) PH31333A (fr)
PL (1) PL179120B1 (fr)
RU (1) RU2142803C1 (fr)
ZA (1) ZA951798B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US5840718A (en) * 1997-03-06 1998-11-24 Hoffmann-La Roche Inc. 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
JPH10316652A (ja) * 1997-05-02 1998-12-02 Duphar Internatl Res Bv １６−デヒドロビタミンｄ化合物の製造方法
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
WO2000051554A2 (fr) * 1999-03-05 2000-09-08 Johns Hopkins University Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) * 1986-08-05 1988-02-22 Mitsubishi Electric Corp 階調補正方式
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.

Also Published As

Publication number Publication date
KR100360732B1 (ko) 2003-03-04
DE69502223T2 (de) 1998-10-29
PH31333A (en) 1998-07-06
CA2141652A1 (fr) 1995-09-12
EP0671387B1 (fr) 1998-04-29
JPH07258208A (ja) 1995-10-09
FI112323B (fi) 2003-11-28
CN1051227C (zh) 2000-04-12
DK0671387T3 (da) 1998-10-07
AU687972B2 (en) 1998-03-05
RU95103438A (ru) 1997-02-10
AU1364495A (en) 1995-09-21
KR950032046A (ko) 1995-12-20
FI951134A (fi) 1995-09-12
HUT70746A (en) 1995-10-30
NZ270624A (en) 1996-06-25
US5384314A (en) 1995-01-24
ZA951798B (en) 1996-08-14
CZ63295A3 (en) 1995-11-15
ES2116634T3 (es) 1998-07-16
HU219906B (hu) 2001-09-28
DE69502223D1 (de) 1998-06-04
IL112887A0 (en) 1995-06-29
NO950920D0 (no) 1995-03-10
FI951134A0 (fi) 1995-03-10
RU2142803C1 (ru) 1999-12-20
CA2141652C (fr) 2006-05-09
NO950920L (no) 1995-09-12
JP2659345B2 (ja) 1997-09-30
PL179120B1 (pl) 2000-07-31
BR9501035A (pt) 1995-10-31
CZ288793B6 (cs) 2001-09-12
CN1112918A (zh) 1995-12-06
ATE165595T1 (de) 1998-05-15
PL307629A1 (en) 1995-09-18
HU9500666D0 (en) 1995-04-28
US5384314B1 (en) 1997-08-05
EP0671387A1 (fr) 1995-09-13

Similar Documents

Publication Publication Date Title
NO307782B1 (no) Anvendelse av fluorinert vitamin D3-derivat
ATE163179T1 (de) Vitamin-d3-analoge
YU3902A (sh) Imidazoimidazoli i triazoli kao anti-inflamatorna sredstva
MXPA04005376A (es) Composiciones farmaceuticas y sus usos.
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
CA2390295A1 (fr) Chimio-prevention du cancer de la prostate
CA2157142A1 (fr) Traitement des maladies causees par les desordres de la glande sebacee
WO2005056042A3 (fr) Methodes de protection contre les radiations au moyen de flagelline
YU19997A (sh) Analozi fluorovanog vitamina d3
AU2002308337A1 (en) Compounds and methods for inhibiting axillary malodour
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
RU94045256A (ru) Применение бензо[g]хинолинов
ES2164454T3 (es) Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.
BR0113175A (pt) Derivados da quinolina como agentes antiinflamação
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
EP0796843A3 (fr) Dérivés de 1,25-dihydroxy-16,22,23-trisdéhydro-cholecalciférol
AU2003207024A1 (en) Spermidine derivatives for the treatment of chronic neurodegenerative diseases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002